Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 ... pointing to a durable effect for a drug that could provide an alternative to injectables.

Results 163 articles published between 1989 and 2020 met eligibility criteria. 75 studies described details for MAID administered by intravenous medications and 50 studies provided data on oral ...

Treatments for mental health conditions are structured around the condition being treated and typically are holistic in nature- including not just medication but also other interventions, such as ...

There are no effective drugs to treat BKPyV. Research reveals new aspects of BKPyV replication, offering possible drug ... Network-Based Analyses Uncover How Neuroinflammation-Causing Microglia in ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. The role of ...